Literature DB >> 30408148

Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK's population-based Haematological Malignancy Research Network.

Daniel Painter1, Sharon Barrans2, Stuart Lacy1, Alexandra Smith1, Simon Crouch1, David Westhead3, Chulin Sha3, Russell Patmore4, Reuben Tooze5, Cathy Burton2, Eve Roman1.   

Abstract

Entities:  

Keywords:  gene-expression; prognostic factors; survival, epidemiology

Mesh：

Substances：

Year:  2018        PMID： 30408148     DOI： 10.1111/bjh.15619

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppression.

Authors:  Xu Cao; Yingyu Wang; Wencan Zhang; Xiancai Zhong; E Gulsen Gunes; Jessica Dang; Jinhui Wang; Alan L Epstein; Christiane Querfeld; Zuoming Sun; Steven T Rosen; Mingye Feng
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

2.  Identification of FCER1G related to Activated Memory CD4+ T Cells Infiltration by Gene Co-expression Network and Construction of a Risk Prediction Module in Diffuse Large B-Cell Lymphoma.

Authors:  Xiaoyu Xiang; Li-Min Gao; Yuehua Zhang; Yuan Tang; Sha Zhao; Weiping Liu; Yunxia Ye; Wenyan Zhang
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

3.  End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA.

Authors:  Lale Kostakoglu; Maurizio Martelli; Laurie H Sehn; David Belada; Angelo-Michele Carella; Neil Chua; Eva Gonzalez-Barca; Xiaonan Hong; Antonio Pinto; Yuankai Shi; Yoichi Tatsumi; Andrea Knapp; Federico Mattiello; Tina Nielsen; Deniz Sahin; Gila Sellam; Mikkel Z Oestergaard; Umberto Vitolo; Marek Trněný
Journal:  Blood Adv       Date:  2021-03-09

4.  The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.

Authors:  Eleanor Kane; Daniel Painter; Alexandra Smith; Simon Crouch; Steven Oliver; Russell Patmore; Eve Roman
Journal:  Cancer Epidemiol       Date:  2019-03-04       Impact factor: 2.984

5.  Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.

Authors:  Francesco Cucco; Sharon Barrans; Chulin Sha; Alexandra Clipson; Simon Crouch; Rachel Dobson; Zi Chen; Joe Sneath Thompson; Matthew A Care; Thomas Cummin; Josh Caddy; Hongxiang Liu; Anne Robinson; Anna Schuh; Jude Fitzgibbon; Daniel Painter; Alexandra Smith; Eve Roman; Reuben Tooze; Catherine Burton; Andrew J Davies; David R Westhead; Peter W M Johnson; Ming-Qing Du
Journal:  Leukemia       Date:  2019-12-16       Impact factor: 11.528

6.  Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.

Authors:  Eve Roman; Eleanor Kane; Debra Howell; Maxine Lamb; Timothy Bagguley; Simon Crouch; Daniel Painter; Russell Patmore; Alexandra Smith
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

7.  CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma.

Authors:  Morihiro Higashi; Shuji Momose; Natsuko Takayanagi; Yuka Tanaka; Tomoe Anan; Takahisa Yamashita; Jun Kikuchi; Michihide Tokuhira; Masahiro Kizaki; Jun-Ichi Tamaru
Journal:  J Pathol Clin Res       Date:  2022-03-14

8.  Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.

Authors:  Stuart E Lacy; Sharon L Barrans; Philip A Beer; Daniel Painter; Alexandra G Smith; Eve Roman; Susanna L Cooke; Camilo Ruiz; Paul Glover; Suzan J L Van Hoppe; Nichola Webster; Peter J Campbell; Reuben M Tooze; Russell Patmore; Cathy Burton; Simon Crouch; Daniel J Hodson
Journal:  Blood       Date:  2020-05-14       Impact factor: 25.476

9.  Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma.

Authors:  Maysaa Abdulla; Peter Hollander; Tatjana Pandzic; Larry Mansouri; Susanne Bram Ednersson; Per-Ola Andersson; Magnus Hultdin; Maja Fors; Martin Erlanson; Sofie Degerman; Helga Munch Petersen; Fazila Asmar; Kirsten Grønbaek; Gunilla Enblad; Lucia Cavelier; Richard Rosenquist; Rose-Marie Amini
Journal:  Am J Hematol       Date:  2019-11-07       Impact factor: 10.047
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.